Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2
2(100.0%)
2Total
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04675762Phase 2Recruiting

Combinating Fingolimod With Alteplase Bridging With Thrombectomy in Acute Ischemic Stroke

Role: collaborator

NCT04487340Recruiting

Computer-based Online Database of Acute Stroke Patients for Stroke Management Quality Evaluation

Role: collaborator

NCT02956200Phase 2Withdrawn

Combinating Fingolimod With Alteplase Bridging With Mechanical Thrombectomy in Acute Ischemic Stroke

Role: collaborator

All 3 trials loaded